The data presented here clearly showed that placental KP differentially affected proliferation, invasion, adhesion, and motility of ER-negative and ER-positive breast cancer cells possibly by modulation of pro-inflammatory cytokine production and that in most instances such effects were in parallel to and in some instances stronger than what was exerted by synthetic KP-10. Here, ESR1 is linked to breast cancer.